Table 1.
Demographic and characteristic features of CFI, CRC and CLM patient blood samples were used to identify lipids. CFI - cancer free individuals; CRC - colorectal cancer; CLM - colorectal cancer liver metastasis; TA - tubular adenomas; VA – villous adenomas; TVA - tubulovillous adenomas; SSA – sessile serrated adenomas; HP – hyperplastic polyps; LGD - low-grade dysplasia. Measurement medians in brackets
| Characteristics | CFI | CRC | CLM |
|---|---|---|---|
| Sample size, n | 29 | 78 | 18 |
| Age | 34–82 (57) | 38–89 (67.5) | 42–81 (65.5) |
| Gender | |||
| Female, n | 19 | 32 | 9 |
| Male, n | 11 | 46 | 9 |
| Waist size (cm) | 78–123 (108) | 77–141 (111) | 85–117 (94) |
| Cancer stage | |||
| Stage 0, n (No residual of adenomatous, malignancy, carcinomatous or tumour) | - | 16 | - |
| Stage-I, n | - | 12 | - |
| Stage-II, n | - | 14 | - |
| Stage-III, n | - | 18 | - |
| Stage-IV, n | - | 16 | - |
| Pathology |
Polyp and adenomas development. Had positive ascending colon tumour |
Liver lesion believed to be metastatic | |
| Pathological type (polyps and adenomas) | - |
< 6 x TA LGD, 1 x TVA LGD 1 x VA LGD 6 x SSA, 2 x HP |
2 x TA LGD, 4 x HP |